Direct brain infusion of glial cell line–derived neurotrophic factor in Parkinson disease

Gill, Steven S., Patel, Nikunj K., Hotton, Gary R., O'Sullivan, Karen, McCarter, Renée, Bunnage, Martin, Brooks, David J., Svendsen, Clive N. +1 more·2003·Nature Medicine

DOI 10.1038/nm850

Cited by (1,000)

Items 201–300 of 1,000

Image-guided, direct convective delivery of glucocerebrosidase for neuronopathic Gaucher disease
Russell R. Lonser, Raphael Schiffman, Aaron Robison, John A. Butman, Zenaide Quezado, Marion L. Walker, Paul F. Morrison, Stuart Walbridge, Gary J. Murray, D. M. Park et al. · 2006 · Neurology
Immune Privilege as an Intrinsic CNS Property: Astrocytes Protect the CNS against T-Cell-Mediated Neuroinflammation
Ulrike Gimsa, Nicholas Avrion Mitchison, Monika Christine Brunner-Weinzierl · 2013 · Mediators of Inflammation
Mesenchymal stem cells and neuroregeneration in Parkinson's disease
Aleksandra Glavaski‐Joksimovic, Martha Churchill Bohn · 2013 · Experimental Neurology
Targeting the CNS to treat type 2 diabetes
Darleen A. Sandoval, Silvana Obici, Randy J. Seeley · 2009 · Nature Reviews Drug Discovery
Anti-inflammatory and Neuroprotective Agents in Clinical Trials for CNS Disease and Injury: Where Do We Go From Here?
Khalil Mallah, Christine Couch, Davis M. Borucki, Amer Toutonji, Mohammed Alshareef, Stephen Tomlinson · 2020 · Frontiers in Immunology
Development of efficient plasmid DNA transfer into adult rat central nervous system using microbubble-enhanced ultrasound
Munehisa Shimamura, Naoyuki Sato, Yoshiaki Taniyama, Satomi Yamamoto, M Endoh, Hitomi Kurinami, Motokuni Aoki, Toshio Ogihara, Yasufumi Kaneda, Ryuichi Morishita · 2004 · Gene Therapy
GDNF-based therapies, GDNF-producing interneurons, and trophic support of the dopaminergic nigrostriatal pathway. Implications for Parkinson’s disease
Xavier d’Anglemont de Tassigny, Alberto Pascual, José López‐Barneo · 2015 · Frontiers in Neuroanatomy
Emerging roles of microglial activation and non-motor symptoms in Parkinson's disease
Karlijn J. Doorn, Paul John Lucassen, H. W. G. M. Boddeke, Marloes Prins, Henk W. Berendse, Benjamin Drukarch, Anne‐Marie van Dam · 2012 · Progress in Neurobiology
Current disease modifying approaches to treat Parkinson’s disease
Lindholm, Dan, Mäkelä, Johanna, Di Liberto, Valentina, Mudò, Giuseppa, Belluardo, Natale, Eriksson, Ove, Saarma, Mart · 2016 · Cellular and Molecular Life Sciences
Parkinson's Disease: Gene Therapies
Philippe Coune, Bernard Laurent Schneider, Patrick Aebischer · 2012 · Cold Spring Harbor Perspectives in Medicine
Functional neurosurgery for movement disorders: a historical perspective
Alim Louis Benabid, Stéphan Chabardès, Napoleon Torres-Martinez, Brigitte Piallat, Paul Krack, Valérie Fraix, Pierre Pollak · 2009 · Progress in brain research
The administration of BDNF and GDNF to the brain via PLGA microparticles patterned within a degradable PEG‐based hydrogel: Protein distribution and the glial response
Kyle J. Lampe, Drew S. Kern, Melissa J. Mahoney, Kimberly B. Bjugstad · 2011 · Journal of Biomedical Materials Research Part A
Clinical tests of neurotrophic factors for human neurodegenerative diseases, part 1: Where have we been and what have we learned?
Bartus, Raymond T., Johnson, Eugene M. · 2017 · Neurobiology of Disease
Trophic factor distribution predicts functional recovery in parkinsonian monkeys
Don Marshall Gash, Zhiming Zhang, Yi Ai, Richard Grondin, Robert J. Coffey, Greg A. Gerhardt · 2005 · Annals of Neurology
Gene therapy with AAV 2‐ CDNF provides functional benefits in a rat model of P arkinson's disease
Susanne Bäck, Johan Peränen, Emilia Galli, Päivi Lindholm, Liina Lonka‐Nevalaita, Tuulia Tamminen, Merja H. Voutilainen, Atso Raasmaja, Märt Saarma, Pekka T. Männistö et al. · 2013 · Brain and Behavior
Combining growth factor and stem cell therapy for amyotrophic lateral sclerosis
Masatoshi Suzuki, Clive N. Svendsen · 2008 · Trends in Neurosciences
Emerging therapies for Parkinson's disease: From bench to bedside
Frank I. Tarazi, Zeyad T. Sahli, M. Wolny, Shaker A. Mousa · 2014 · Pharmacology & Therapeutics
Physiological neuroprotection by melatonin in a 6-hydroxydopamine model of Parkinson's disease
Rohita Sharma, Catherine R. McMillan, Catherine C. Tenn, Lennard P. Niles · 2005 · Brain Research
Angels and demons: neurotrophic factors and epilepsy
Michele Simonato, Enrico Tongiorgi, Mérab Kokaia · 2006 · Trends in Pharmacological Sciences
Functional Effects of AAV2-GDNF on the Dopaminergic Nigrostriatal Pathway in Parkinsonian Rhesus Monkeys
Jamie L. Eberling, Adrian P. Kells, Philip Pivirotto, Janine Beyer, John Bringas, Howard J. Federoff, John Forsayeth, Krystof S. Bankiewicz · 2009 · Human Gene Therapy
Nerve Growth Factor Gene Therapy in Alzheimer Disease
Mark H. Tuszynski · 2007 · Alzheimer Disease & Associated Disorders
Striatal volume differences between non-human and human primates
Dali Yin, Francisco E. Valles, Massimo S. Fiandaca, John Forsayeth, Paul Larson, Phillip A. Starr, Krystof S. Bankiewicz · 2008 · Journal of Neuroscience Methods
Encapsulated GDNF-producing C2C12 cells for Parkinson's disease: a pre-clinical study in chronic MPTP-treated baboons
Haruhiko Kishima, Thomas Poyot, Jocelyne Bloch, Julien Dauguet, Françoise Condé, Frédéric Dollé, Françoise Hinnen, W F Pralong, Stéphane Palfi, Nicole Déglon et al. · 2004 · Neurobiology of Disease
The GDNF Family: A Role in Cancer?
Graeme C. Fielder, Teresa Wen-Shan Yang, Mahalakshmi Razdan, Yan Li, Jun Lu, Jo Kate Perry, Peter Edward Lobie, Dong‐Xu Liu · 2017 · Neoplasia
Ultrasound-responsive neurotrophic factor-loaded microbubble- liposome complex: Preclinical investigation for Parkinson's disease treatment
Chung‐Yin Lin, Yu-Chien Lin, Ching-Yun Huang, Shang-Rung Wu, Chiung‐Mei Chen, Hao-Li Liu · 2020 · Journal of Controlled Release
GDNF Is Predominantly Expressed in the PV+ Neostriatal Interneuronal Ensemble in Normal Mouse and after Injury of the Nigrostriatal Pathway
María Hidalgo‐Figueroa, Sonia Bonilla, Francisco Gutiérrez, Alberto Pascual, José López‐Barneo · 2012 · Journal of Neuroscience
Sustained local delivery of bioactive nerve growth factor in the central nervous system via tunable diblock copolypeptide hydrogel depots
Bingbing Song, Jinsuk Song, Shanshan Zhang, Mark A. Anderson, Yan Ao, Chu-Ya Yang, Timothy J. Deming, Michael V. Sofroniew · 2012 · Biomaterials
Real-time Imaging and Quantification of Brain Delivery of Liposomes
Michal Tadeusz Krauze, John Forsayeth, John W. Park, Krystof S. Bankiewicz · 2006 · Pharmaceutical Research
Acceleration of the direct reconstruction of linear parametric images using nested algorithms
Guobao Wang, Jinyi Qi · 2010 · Physics in Medicine and Biology
Severity of Neurodegeneration Correlates with Compromise of Iron Metabolism in Mice with Iron Regulatory Protein Deficiencies
Sophia Smith, Sharon S. Cooperman, Timothy M. LaVaute, Nancy J. Tresser, Manik Chandra Ghosh, Esther G. Meyron‐Holtz, William Land, Hayden Ollivierre, Bernard S. Jortner, Robert Switzer et al. · 2004 · Annals of the New York Academy of Sciences
Neurotrophic Factors and Their Potential Applications in Tissue Regeneration
Xiao, Nan, Le, Quynh-Thu · 2016 · Archivum Immunologiae et Therapiae Experimentalis
Induction of Adult Human Bone Marrow Mesenchymal Stromal Cells into Functional Astrocyte-Like Cells: Potential for Restorative Treatment in Parkinson’s Disease
Merav Bahat-Stromza, Yael Barhum, Yossef S. Levy, Olga Karpov, Shlomo Bulvik, Eldad Melamed, Daniel Offen · 2009 · Journal of Molecular Neuroscience
GDNF signaling implemented by GM1 ganglioside; failure in Parkinson's disease and GM1-deficient murine model
Piotr Hadaczek, Gusheng Wu, Nitasha Sharma, Agnieszka Ciesielska, Krystof S. Bankiewicz, Amy L. Davidow, Zihua Lu, John Forsayeth, Robert W. Ledeen · 2014 · Experimental Neurology
Real-time visualization and characterization of liposomal delivery into the monkey brain by magnetic resonance imaging
Michal Tadeusz Krauze, Tracy Richmond McKnight, Yoji Yamashita, John Bringas, Charles O. Noble, Ryuta Saito, Karsten Geletneky, John Forsayeth, Mitchel Stuart Berger, Pamela Jackson et al. · 2005 · Brain Research Protocols
Neuroimaging in Parkinson’s disease
D. Brooks · 2004 · NeuroRx
Chronic convection-enhanced delivery of topotecan for patients with recurrent glioblastoma: a first-in-patient, single-centre, single-arm, phase 1b trial
Eleonora F. Spinazzi, Michael Argenziano, Pavan S. Upadhyayula, Matei A. Banu, Justin Anthony Neira, Dominique M. O. Higgins, Peter B. Wu, Brianna Pereira, Aayushi Mahajan, Nelson Humala et al. · 2022 · The Lancet Oncology
Calcitriol Imparts Neuroprotection In Vitro to Midbrain Dopaminergic Neurons by Upregulating GDNF Expression
Rowan P. Orme, Manminder S. Bhangal, Rosemary A. Fricker · 2013 · PLoS ONE
Huntington’s Disease
Chiara Zuccato, Elena F. Cattaneo · 2014 · Handbook of experimental pharmacology
Therapeutic potential of controlled drug delivery systems in neurodegenerative diseases
Natalija Popović, Patrik Brundin · 2006 · International Journal of Pharmaceutics
Genetic contributions to Parkinson's disease
Yue Ming Huang, Linda Cheung, Dominic B. Rowe, Glenda Margaret Halliday · 2004 · Brain Research Reviews
Therapeutic Potential of Neurotrophic Factors in Neurodegenerative Diseases
Yossef S. Levy, Yossi Gilgun‐Sherki, Eldad Melamed, Daniel Offen · 2005 · BioDrugs
Astrocyte‐only Npc1 reduces neuronal cholesterol and triples life span of Npc1–/– mice
Min Zhang, Diana Strnatka, Carolyn Donohue, Janice L. Hallows, Inez J. Vincent, Robert P. Erickson · 2008 · Journal of Neuroscience Research
Neurotrophic Factors in Parkinson’s Disease: Clinical Trials, Open Challenges and Nanoparticle-Mediated Delivery to the Brain
Olesja M. Bondarenko, Märt Saarma · 2021 · Frontiers in Cellular Neuroscience
Clinically Relevant Effects of Convection-Enhanced Delivery of AAV2-GDNF on the Dopaminergic Nigrostriatal Pathway in Aged Rhesus Monkeys
Louisa C. Johnston, Jamie L. Eberling, Philip Pivirotto, Piotr Hadaczek, Howard J. Federoff, John Forsayeth, Krystof S. Bankiewicz · 2009 · Human Gene Therapy
Convection-Enhanced Delivery in the Treatment of Epilepsy
Michael A. Rogawski · 2009 · Neurotherapeutics
CDNF Protein Therapy in Parkinson’s Disease
Henri J. Huttunen, Märt Saarma · 2019 · Cell Transplantation
Lentivector‐mediated delivery of GDNF protects complex motor functions relevant to human Parkinsonism in a rat lesion model
Eilís Dowd, Christelle Monville, Eduardo M. Torres, Liang‐Fong Wong, Mimoun Azzouz, Nicholas D. Mazarakis, Stephen B. Dunnett · 2005 · European Journal of Neuroscience
Regulation of the Development of Mesencephalic Dopaminergic Systems by the Selective Expression of Glial Cell Line-Derived Neurotrophic Factor in Their Targets
Nikolai G. Kholodilov, Olga Yarygina, Tinmarla Frances Oo, Hui Zhang, David L. Sulzer, William T. Dauer, Robert E. Burke · 2004 · Journal of Neuroscience
GDNF-secreting mesenchymal stem cells provide localized neuroprotection in an inflammation-driven rat model of Parkinson’s disease
Deirdre B. Hoban, Linda Howard, Eilís Dowd · 2015 · Neuroscience
The monoacylglycerol lipase inhibitor JZL184 is neuroprotective and alters glial cell phenotype in the chronic MPTP mouse model
Diana Fernández‐Suárez, Marta Celorrio, José Ignacio Riezu‐Boj, Ana Ugarte, Rodrigo Pacheco, Hugo González, Julen Oyarzábal, Cecilia J. Hillard, Rafael Franco, María S. Aymerich · 2014 · Neurobiology of Aging
GDNF applied to the MPTP-lesioned nigrostriatal system requires TGF-β for its neuroprotective action
Andreas Schober, Heike Peterziel, Christopher S. von Bartheld, Horst H. Simon, Kerstin G. KRIEGLSTEIN, Klaus Unsicker · 2006 · Neurobiology of Disease
Comparative Analysis of the Effects of Neurotrophic Factors CDNF and GDNF in a Nonhuman Primate Model of Parkinson’s Disease
Enrique Garea‐Rodríguez, Ave Eesmaa, Päivi Lindholm, Christina Schlumbohm, Jessica König, Birgit Meller, Kerstin G. KRIEGLSTEIN, Gunther Helms, Märt Saarma, Eberhard Fuchs · 2016 · PLoS ONE
Gene therapy progress and prospects: Parkinson's disease
Edward A. Burton, Joseph C. Glorioso, D J Fink · 2003 · Gene Therapy
Antiepileptic Effect of Gap‐junction Blockers in a Rat Model of Refractory Focal Cortical Epilepsy
Karen E. Nilsen, Andrew R. C. Kelso, Hannah R. Cock · 2006 · Epilepsia
Enhanced Efficacy of the CDNF/MANF Family by Combined Intranigral Overexpression in the 6-OHDA Rat Model of Parkinson's Disease
Oscar Cordero Llana, Benjamin Christopher Houghton, Federica Rinaldi, Hannah Taylor, Rafael J. Yáñez‐Muñoz, James B. Uney, Liang‐Fong Wong, Maeve A. Caldwell · 2014 · Molecular Therapy
The Potential Role of Vascular Endothelial Growth Factor in the Central Nervous System
Takao Yasuhara, Tetsuro Shingo, Isao Date · 2004 · Reviews in the Neurosciences
Maximuma posteriorireconstruction of the Patlak parametric image from sinograms in dynamic PET
Guobao Wang, Lin Fu, Jinyi Qi · 2008 · Physics in Medicine and Biology
Hippocampal dysfunctions caused by cranial irradiation: A review of the experimental evidence
Yeonghoon Son, Miyoung Yang, Hongbing Wang, Changjong Moon · 2015 · Brain Behavior and Immunity
Progress in neuroprotection in Parkinson’s disease
Anthony H.V. Schapira · 2008 · European Journal of Neurology
Optimized cannula design and placement for convection-enhanced delivery in rat striatum
Dali Yin, John Forsayeth, Krystof S. Bankiewicz · 2009 · Journal of Neuroscience Methods
Potential of rat bone marrow-derived mesenchymal stem cells as vehicles for delivery of neurotrophins to the Parkinsonian rat brain
Teresa C. Moloney, Gemma E. Rooney, Frank Barry, Linda Howard, Eilís Dowd · 2010 · Brain Research
Ex vivo delivery of GDNF maintains motor function and prevents neuronal loss in a transgenic mouse model of Huntington's disease
Allison D. Ebert, Amelia E. Barber, Brittany M. Heins, Clive Niels Svendsen · 2010 · Experimental Neurology
Anterograde Axonal Transport of AAV2-GDNF in Rat Basal Ganglia
Agnieszka Ciesielska, Gabriele Mittermeyer, Piotr Hadaczek, Adrian P. Kells, John Forsayeth, Krystof S. Bankiewicz · 2010 · Molecular Therapy
MAGNETIC RESONANCE IMAGING-DIRECTED METHOD FOR FUNCTIONAL NEUROSURGERY USING IMPLANTABLE GUIDE TUBES
Nikunj K. Patel, Puneet Plaha, Steven S. Gill · 2007 · Operative Neurosurgery
Neurotrophic factors as a therapeutic target for Parkinson's disease
Jonathan Evans, Roger A. Barker · 2008 · Expert Opinion on Therapeutic Targets
Post-mortem assessment of the short and long-term effects of the trophic factor neurturin in patients with α-synucleinopathies
Raymond T. Bartus, Jeffrey H. Kordower, Eugene M. Johnson, Lamar Brown, Brian R. Kruegel, Yaping Chu, Tiffany L. Baumann, Anthony Edward Lang, C. Warren Olanow, Christopher D. Herzog · 2015 · Neurobiology of Disease
Striatal expression of GDNF and differential vulnerability of midbrain dopaminergic cells
Pedro Barroso‐Chinea, Ignacio Cruz‐Muros, María S. Aymerich, Manuel Rodrı́guez, Domingo Afonso‐Oramas, José Luis Lanciego, Tomás González‐Hernández · 2005 · European Journal of Neuroscience
Use of Genetically Modified Mesenchymal Stem Cells to Treat Neurodegenerative Diseases
Robert D. Wyse, Gary Leo Dunbar, Julien Rossignol · 2014 · International Journal of Molecular Sciences
A Specific Survival Response in Dopamine Neurons at Most Risk in Parkinson's Disease
Sachiko Murase, Ronald D.G. McKay · 2006 · Journal of Neuroscience
Adeno-associated viral vector-mediated gene transfer of brain-derived neurotrophic factor reverses atrophy of rubrospinal neurons following both acute and chronic spinal cord injury
Marc Jan Ruitenberg, Bas Blits, Paul A. Dijkhuizen, Erik T. te Beek, Arne Bakker, Joop J. van Heerikhuize, C.W. Pool, Wim T.J Hermens, Gerard J. Boer, Joost Verhaagen · 2004 · Neurobiology of Disease
Structure of Artemin Complexed with Its Receptor GFRα3: Convergent Recognition of Glial Cell Line-Derived Neurotrophic Factors
Xinquan Wang, Robert H. Baloh, Jeffrey Milbrandt, K. Christopher García · 2006 · Structure
Systemic administration of neuregulin‐1β1 protects dopaminergic neurons in a mouse model of Parkinson’s disease
Thomas Carlsson, Friederike Rebecca Schindler, Matthias Höllerhage, Candan Depboylu, Óscar Arias-Carrión, Stefan Schnurrbusch, Thomas W. Rösler, Wojciech Woźny, Gerhard Schwall, Karlfried Groebe et al. · 2011 · Journal of Neurochemistry
Transient striatal delivery of GDNF via encapsulated cells leads to sustained behavioral improvement in a bilateral model of Parkinson disease
Ali Sajadi, Jean‐Charles Bensadoun, Bernard Laurent Schneider, Christophe Lo Bianco, Patrick Aebischer · 2005 · Neurobiology of Disease
Long-term Transgene Expression in the Central Nervous System Using DNA Nanoparticles
David M. Yurek, Anita M. Fletcher, George M. Smith, Kim B. Seroogy, Assem G. Ziady, Joseph P. Molter, Tomasz H Kowalczyk, Linas Padegimas, Mark J. Cooper · 2009 · Molecular Therapy
Stroke and TGF-β proteins: glial cell line-derived neurotrophic factor and bone morphogenetic protein
Brandon K. Harvey, Barry J. Hoffer, Yun Wang · 2004 · Pharmacology & Therapeutics
Treatment of Parkinson???s Disease
Stacy Wu, Steven J. Frucht · 2005 · CNS Drugs
PYM50028, a novel, orally active, nonpeptide neurotrophic factor inducer, prevents and reverses neuronal damage induced by MPP + in mesencephalic neurons and by MPTP in a mouse model of Parkinson's disease
Naomi P. Visanji, Antonia Orsi, Tom H. Johnston, Patrick A. Howson, Kimberly Dixon, Noëlle Callizot, Jonathan M. Brotchie, Daryl D. Rees · 2008 · The FASEB Journal
Glial cell line‐derived neurotrophic factor–secreting genetically modified human bone marrow‐derived mesenchymal stem cells promote recovery in a rat model of Parkinson's disease
Aleksandra Glavaski‐Joksimovic, Tamás Virág, Thomas A. Mangatu, Michael P. McGrogan, Xue Song Wang, Martha Churchill Bohn · 2010 · Journal of Neuroscience Research
GDNF-Secreting Human Neural Progenitor Cells Increase Tyrosine Hydroxylase and VMAT2 Expression in MPTP-Treated Cynomolgus Monkeys
Marina Elena Emborg, Allison D. Ebert, Jeffrey M. Moirano, Sun Choon Peng, Masatoshi Suzuki, Elizabeth E. Capowski, Valerie L. Joers, Ben Zion Roitberg, Patrick Aebischer, Clive Niels Svendsen · 2008 · Cell Transplantation
Targeting the Progression of Parkinsons Disease
George, J., Mok, S., Moses, D., Wilkins, S., Bush, A., Cherny, R., Finkelstein, D. · 2009 · Current Neuropharmacology
Neurotensin polyplex as an efficient carrier for delivering the human GDNF gene into nigral dopamine neurons of hemiparkinsonian rats
Juan Antonio González-Barrios, Maria Lindahl, Michael J. Bannon, Verónica Anaya-Martı́nez, Gonzalo Flores, Iván Navarro-Quiroga, Louis‐Éric Trudeau, Jorge Aceves, Daniel Benjamin Martinez-Arguelles, Refugio Garcı́a-Villegas et al. · 2006 · Molecular Therapy
The key role of adult stem cells: therapeutic perspectives
Augusto Pessina, Laura Gribaldo · 2006 · Current Medical Research and Opinion
GDNF delivery for Parkinson’s disease
Nikunj K. Patel, Steven S. Gill · 2007 · Springer eBooks
Altered glial cell line-derived neurotrophic factor (GDNF) concentrations in the brain of patients with depressive disorder: A comparative post-mortem study
Michel, Tanja M., Frangou, Sophia, Camara, Sibylle, Thiemeyer, Dorothea, Jecel, Julia, Tatschner, Thomas, Zoechling, Robert, Grünblatt, Edna · 2008 · European Psychiatry
Application of a blood–brain-barrier-penetrating form of GDNF in a mouse model for Parkinson's disease
Gunnar P.H. Dietz, Paola Valbuena, Birgit Dietz, Katrin Meuer, Patrick Müller, Jochen Hans Weishaupt, Mathias Bähr · 2006 · Brain Research
Prospects of Neurotrophic Factors for Parkinson's Disease: Comparison of Protein and Gene Therapy
Andrii Domanskyi, Märt Saarma, Mikko Airavaara · 2015 · Human Gene Therapy
An Optimization Transfer Algorithm for Nonlinear Parametric Image Reconstruction From Dynamic PET Data
Guobao Wang, Jinyi Qi · 2012 · IEEE Transactions on Medical Imaging
EXPRESSION, BIOACTIVITY, AND SAFETY 1 YEAR AFTER ADENO-ASSOCIATED VIRAL VECTOR TYPE 2–MEDIATED DELIVERY OF NEURTURIN TO THE MONKEY NIGROSTRIATAL SYSTEM SUPPORT CERE-120 FOR PARKINSON'S DISEASE
Christopher D. Herzog, Lamar Brown, Dawn Gammon, Brian R. Kruegel, Richard Lin, Alistair Wilson, Ariadne Bolton, Marie A. Printz, Mehdi Gasmi, Kathie M. Bishop et al. · 2009 · Neurosurgery
Constitutive Ret Activity in Knock-In Multiple Endocrine Neoplasia Type B Mice Induces Profound Elevation of Brain Dopamine Concentration via Enhanced Synthesis and Increases the Number of TH-Positive Cells in the Substantia Nigra
Jelena Mijatovic, Mikko Airavaara, Anu Planken, Petri Auvinen, Atso Raasmaja, Petteri T. Piepponen, Frank D. Costantini, Liisa Ahtee, Märt Saarma · 2007 · Journal of Neuroscience
Lentiviral vector-mediated genetic modification of human neural progenitor cells for ex vivo gene therapy
Elizabeth E. Capowski, Bernard Laurent Schneider, Allison D. Ebert, Corey R. Seehus, Jolanta Szulc, Romain Zufferey, Patrick Aebischer, Clive Niels Svendsen · 2007 · Journal of Neuroscience Methods
Chronic, intermittent convection-enhanced delivery devices
Owen T. Lewis, Max Woolley, David Johnson, Anne Rosser, Neil U. Barua, Alison S. Bienemann, Steven S. Gill, Samuel Lewin Evans · 2015 · Journal of Neuroscience Methods
RET Receptor Tyrosine Kinase: Role in Neurodegeneration, Obesity, and Cancer
Arun Kumar Mahato, Yulia A. Sidorova · 2020 · International Journal of Molecular Sciences
Effects of the perivascular space on convection-enhanced delivery of liposomes in primate putamen
Michal Tadeusz Krauze, Ryuta Saito, Charles O. Noble, John R. Bringas, John Forsayeth, Tracy Richmond McKnight, Jason Y. Park, Krys S. Bankiewicz · 2005 · Experimental Neurology
A Monoclonal Antibody-GDNF Fusion Protein Is Not Neuroprotective and Is Associated with Proliferative Pancreatic Lesions in Parkinsonian Monkeys
Sachiko Ohshima-Hosoyama, Heather A. Simmons, Nichole C. Goecks, Valerie L. Joers, Christine R. Swanson, Viktoriya Bondarenko, Rebecca Velotta, Kevin G. Brunner, Laura DeLong Wood, Ralph H. Hruban et al. · 2012 · PLoS ONE
GDNF and protection of adult central catecholaminergic neurons
Alberto Pascual, María Hidalgo‐Figueroa, Raquel Gómez-Díaz, José López‐Barneo · 2011 · Journal of Molecular Endocrinology
Cell replacement therapy for Parkinson's disease
Ruwani Wijeyekoon, Roger A. Barker · 2008 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Induction of Hyperintense Signal on T2-Weighted MR Images Correlates with Infusion Distribution from Intracerebral Convection-Enhanced Delivery of a Tumor-Targeted Cytotoxin
John Howard Sampson, Raghu Raghavan, James M. Provenzale, David J. Croteau, David A. Reardon, Robert Edward Coleman, Inmaculada Rodríguez Ponce, Ira H Pastan, Raj K. Puri, Christoph Pedain · 2007 · American Journal of Roentgenology
Transgene Expression, Bioactivity, and Safety of CERE-120 (AAV2-Neurturin) Following Delivery to the Monkey Striatum
Herzog, Christopher D, Dass, Biplob, Gasmi, Mehdi, Bakay, Roy, Stansell, James E, Tuszynski, Mark, Bankiewicz, Krystof, Chen, Er-Yun, Chu, Yaping, Bishop, Kathie et al. · 2008 · Molecular Therapy
Neurotrophic factors for the treatment of Parkinson's disease
Aideen M. Sullivan, André Toulouse · 2011 · Cytokine & Growth Factor Reviews
Trophic factors therapy in Parkinson's disease
Ramaswamy, Shilpa, Soderstrom, Katherine E., Kordower, Jeffrey H. · 2009 · Progress in Brain Research